Inventor
Francois-Rene Alexandre
Inventor
Montpellier, FR
Overview
Patents· 26 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07DHeterocyclic compounds19%
A61KPreparations for medical, dental or toiletry purposes18%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium13%
C07HSugars8%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry6%
C07CAcyclic or carbocyclic compounds6%
C07KPeptides3%
H01SDevices using the process of light amplification by stimulated emission of radiation [laser] to amplify or generate light3%
B82YSpecific uses or applications of nanostructures1%
PatentTitleYear
11,040,975Carbocyclic nucleoside reverse transcriptase inhibitors202110,899,788Cyclic phosphate substituted nucleoside compounds and methods of use thereof for the treatment of viral diseases202110,513,5342'-chloro nucleoside analogs for HCV infection201910,202,4113'-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCV20199,353,100'Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections'20169,309,275'3′-deoxy nucleosides for the treatment of HCV'20169,296,778'3′,5′-cyclic phosphate prodrugs for HCV infection'20169,284,307'Macrocyclic serine protease inhibitors'20169,187,496'5,5-fused arylene or heteroarylene hepatitis C virus inhibitors'20159,115,095'Phosphinate ruthenium complexes'20159,109,001'3′,5′-cyclic phosphoramidate prodrugs for HCV infection'20158,993,595'Macrocyclic serine protease inhibitors'20158,765,966'Phosphinate ruthenium complexes'20148,486,991'Enantiomerically pure phosphoindoles as HIV inhibitors'20138,481,748'Phosphinate ruthenium complexes'20138,410,313'Phosphinate ruthenium complexes'20138,377,962'Macrocyclic serine protease inhibitors'20138,362,068'5,5-fused arylene or heteroarylene hepatitis C virus inhibitors'20138,309,737'Phosphinate ruthenium complexes'20128,044,091'Phospho-indoles as HIV inhibitors'20118,003,659'Macrocyclic serine protease inhibitors'20117,960,428'Enantiomerically pure phosphoindoles as HIV inhibitors'20117,534,809'Phospho-indoles as HIV inhibitors'20097,109,526'Semiconductor optical device on an indium phosphide substrate for long operating wavelengths'20065,412,233'Heterojunction bipolar transistor'19954,766,472'Monolithic semiconductor structure of a laser and a field effect transistor'1988Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1988Based in Paris, FR· patent location history
1995Based in Vitry sur Seine, FR· patent location history
2006Based in Marcoussis, FR· patent location history
2009–2016Patents assigned to IDENIX PHARMACEUTICALS INC (16)· patent assignee history
2009–2021Based in Montpellier, FR· patent location history
2012–2016Patents assigned to ALEXANDRE FRANCOIS-RENE (6)· patent assignee history
2012–2016Patents assigned to PARSY CHRISTOPHE CLAUDE (5)· patent assignee history
2012–2016Patents assigned to SURLERAUX DOMINIQUE (5)· patent assignee history
2015–2021Patents assigned to IDENIX PHARMACEUTICALS LLC (8)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IDENIX PHARMACEUTICALS INC | 16 | 2009–2016 |
| IDENIX PHARMACEUTICALS LLC | 8 | 2015–2021 |
| ALEXANDRE FRANCOIS-RENEself | 6 | 2012–2016 |
| PARSY CHRISTOPHE CLAUDE | 5 | 2012–2016 |
| SURLERAUX DOMINIQUE | 5 | 2012–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Montpellier, FR | 23 | 2009–2021 |
| Marcoussis, FR | 1 | 2006 |
| Vitry sur Seine, FR | 1 | 1995 |
| Paris, FR | 1 | 1988 |